FABP4 and colorectal carcinoma: FABP4 knockdown in CTX-DTP CRC cells co-cultured with adipocytes reduced the invasion activity of CTX-DTP CRC cells upon cetuximab treatment, suggesting that targeting FABP4 may inhibit the development of treatment tolerance (Fig. 6E; scale bar = 50 μm).